Development PipelineSGN-B7H4V

an investigational antibody-drug conjugate directed to B7-H4

The safety and efficacy of these investigational compounds, or investigational uses of marketed products, have not been established. For an agent(s) whose safety and efficacy has not been established or confirmed, future regulatory approval or commercial availability is not guaranteed.

Clinical Trials

SGNB7H4V-001: Advanced solid tumors

  • Phase 1

  • Phase 2

  • Phase 3

Program Resources

High-level synopsis of SGN-B7H4V and ongoing clinical trials

Detailed information about SGN-B4V7H clinical trials